“Rising Prevalence of Autoimmune Diseases”
- Rising prevalence of autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease, is significantly increasing the demand for innovative and effective treatments
- Contributing factors include genetic predisposition, environmental triggers, and lifestyle changes, which are driving the growing incidence globally
- For instance, Biologic therapies, such as monoclonal antibodies, have transformed the treatment landscape, offering targeted solutions for managing autoimmune disorders
- The increasing prevalence of autoimmune diseases highlights the urgent need for advancements in research and development to enhance patient outcomes and address unmet medical needs
